266 related articles for article (PubMed ID: 15580324)
1. [Heart transplantation and assist devices].
Görler H; Haverich A
Herz; 2004 Nov; 29(7):695-701. PubMed ID: 15580324
[TBL] [Abstract][Full Text] [Related]
2. Post-cardiac transplant survival after support with a continuous-flow left ventricular assist device: impact of duration of left ventricular assist device support and other variables.
John R; Pagani FD; Naka Y; Boyle A; Conte JV; Russell SD; Klodell CT; Milano CA; Rogers J; Farrar DJ; Frazier OH
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):174-81. PubMed ID: 20447659
[TBL] [Abstract][Full Text] [Related]
3. Postcardiac transplant survival in the current era in patients receiving continuous-flow left ventricular assist devices.
Kamdar F; John R; Eckman P; Colvin-Adams M; Shumway SJ; Liao K
J Thorac Cardiovasc Surg; 2013 Feb; 145(2):575-81. PubMed ID: 23321132
[TBL] [Abstract][Full Text] [Related]
4. [Surgical therapy of end-stage heart failure. State of the art 2006].
Klotz S; Loeher A; Drees G; Scheld HH
Herz; 2006 Aug; 31(5):445-54. PubMed ID: 16944064
[TBL] [Abstract][Full Text] [Related]
5. Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.
John R; Kamdar F; Liao K; Colvin-Adams M; Boyle A; Joyce L
Ann Thorac Surg; 2008 Oct; 86(4):1227-34; discussion 1234-5. PubMed ID: 18805167
[TBL] [Abstract][Full Text] [Related]
6. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
[TBL] [Abstract][Full Text] [Related]
7. Ventricular assist device application as a bridge to pediatric heart transplantation: a single center's experience.
Hsu KH; Huang SC; Chou NH; Chi NH; Tsao CI; Ko WJ; Chen YS; Chang CI; Chiu IS; Wang SS
Transplant Proc; 2012 May; 44(4):883-5. PubMed ID: 22564574
[TBL] [Abstract][Full Text] [Related]
8. The impact of bridge-to-transplant ventricular assist device support on survival after cardiac transplantation.
Bull DA; Reid BB; Selzman CH; Mesley R; Drakos S; Clayson S; Stoddard G; Gilbert E; Stehlik J; Bader F; Kfoury A; Budge D; Eckels DD; Fuller A; Renlund D; Patel AN
J Thorac Cardiovasc Surg; 2010 Jul; 140(1):169-73. PubMed ID: 20451930
[TBL] [Abstract][Full Text] [Related]
9. Impact of ventricular assist device complications on posttransplant survival: an analysis of the United network of organ sharing database.
Healy AH; Baird BC; Drakos SG; Stehlik J; Selzman CH
Ann Thorac Surg; 2013 Mar; 95(3):870-5. PubMed ID: 23218024
[TBL] [Abstract][Full Text] [Related]
10. Improving outcomes with long-term "destination" therapy using left ventricular assist devices.
Long JW; Healy AH; Rasmusson BY; Cowley CG; Nelson KE; Kfoury AG; Clayson SE; Reid BB; Moore SA; Blank DU; Renlund DG
J Thorac Cardiovasc Surg; 2008 Jun; 135(6):1353-60; discussion 1360-1. PubMed ID: 18544385
[TBL] [Abstract][Full Text] [Related]
11. How does successful bridging with ventricular assist device affect cardiac transplantation outcome?
Urban M; Pirk J; Dorazilova Z; Netuka I
Interact Cardiovasc Thorac Surg; 2011 Oct; 13(4):405-9. PubMed ID: 21788304
[TBL] [Abstract][Full Text] [Related]
12. Changing face of heart failure surgery.
Yagdi T; Oguz E; Engin C; Engin Y; Nalbantgil S; Zoghi M; Ozbaran M
Transplant Proc; 2012; 44(6):1729-31. PubMed ID: 22841256
[TBL] [Abstract][Full Text] [Related]
13. Optimal timing of cardiac transplantation after ventricular assist device implantation.
Gammie JS; Edwards LB; Griffith BP; Pierson RN; Tsao L
J Thorac Cardiovasc Surg; 2004 Jun; 127(6):1789-99. PubMed ID: 15173738
[TBL] [Abstract][Full Text] [Related]
14. [Destination therapy in end-stage heart failure. A possible alternative to heart transplantation?].
Olsen PS; Sander K; Hansen PB; Mortensen SA; Gustafsson F; Boesgaard S
Ugeskr Laeger; 2007 Sep; 169(39):3287-9. PubMed ID: 17953887
[TBL] [Abstract][Full Text] [Related]
15. Cardiac prosthesis as an advanced surgical therapy for end-stage cardiac patients: current status and future perspectives.
Takatani S
J Med Dent Sci; 2000 Sep; 47(3):151-65. PubMed ID: 12160228
[TBL] [Abstract][Full Text] [Related]
16. Cardiac extracorporeal life support: state of the art in 2007.
Cooper DS; Jacobs JP; Moore L; Stock A; Gaynor JW; Chancy T; Parpard M; Griffin DA; Owens T; Checchia PA; Thiagarajan RR; Spray TL; Ravishankar C
Cardiol Young; 2007 Sep; 17 Suppl 2():104-15. PubMed ID: 18039404
[TBL] [Abstract][Full Text] [Related]
17. The influence of infection on survival and successful transplantation in patients with left ventricular assist devices.
Argenziano M; Catanese KA; Moazami N; Gardocki MT; Weinberg AD; Clavenna MW; Rose EA; Scully BE; Levin HR; Oz MC
J Heart Lung Transplant; 1997 Aug; 16(8):822-31. PubMed ID: 9286774
[TBL] [Abstract][Full Text] [Related]
18. The future is here: ventricular assist devices for the failing heart.
Alba AC; Delgado DH
Expert Rev Cardiovasc Ther; 2009 Sep; 7(9):1067-77. PubMed ID: 19764860
[TBL] [Abstract][Full Text] [Related]
19. [Indication, management and problems of cardiac transplantation].
Mohacsi P; Carrel T
Ther Umsch; 2005 Jul; 62(7):473-6. PubMed ID: 16075953
[TBL] [Abstract][Full Text] [Related]
20. Cardiac transplantation is still the method of choice in the treatment of patients with severe heart failure.
Korewicki J
Cardiol J; 2009; 16(6):493-9. PubMed ID: 19950084
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
